Mengchao Wei

58 Zhongshan Road 2
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Surgery or external beam radiation for solitary small hepatocellular carcinoma.

Surgery or external beam radiation for solitary small hepatocellular carcinoma.

Journal: Journal of cancer research and therapeutics

Published: May 06, 2023

ASO Author Reflections: Intertumor Biological Heterogeneity Counts in Treatment Selection of Single ≤ 5 cm Hepatocellular Carcinoma.

ASO Author Reflections: Intertumor Biological Heterogeneity Counts in Treatment Selection of Single ≤ 5 cm Hepatocellular Carcinoma.

Journal: Annals of surgical oncology

Published: January 11, 2022

Cost-Effectiveness Analysis of Follow-Up Schedule for Hepatocellular Carcinoma after Radiofrequency Ablation.

Cost-Effectiveness Analysis of Follow-Up Schedule for Hepatocellular Carcinoma after Radiofrequency Ablation.

Journal: Journal of oncology

Published: December 15, 2021

The Combination of Radiation Therapy and Immunotherapy Is Effective and Well-Tolerated for Unresectable Biliary Tract Cancer.

The Combination of Radiation Therapy and Immunotherapy Is Effective and Well-Tolerated for Unresectable Biliary Tract Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: July 27, 2021

Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular Carcinoma.

Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular Carcinoma.

Journal: Annals of surgical oncology

Published: July 20, 2021

Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A.

Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A.

Journal: Annals of surgical oncology

Published: November 25, 2019

TBH score: a new model to predict and prevent severe liver damage after chemotherapy for cancer patients.

TBH score: a new model to predict and prevent severe liver damage after chemotherapy for cancer patients.

Journal: Cancer management and research

Published: December 31, 2018

Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma.

Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma.

Journal: Cancer medicine

Published: December 08, 2018

Radiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis.

Radiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis.

Journal: American journal of translational research

Published: March 18, 2018

Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model.

Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model.

Journal: BMC cancer

Published: March 01, 2018

Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.

Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.

Journal: Radiology

Published: February 02, 2018

Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis.

Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis.

Journal: BMC cancer

Published: August 18, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026